SCHEMBL18135487

SCHEMBL18135487

c1ccc(-c2ccc3[nH]c4cnccc4c3c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHUK O15111 7/20 0.64
GABRA1 P14867 3/20 0.64
GABRG2 P18507 3/20 0.64
GABRB3 P28472 3/20 0.64
GABRA5 P31644 3/20 0.64
GABRA3 P34903 3/20 0.64
GABRA2 P47869 3/20 0.64
GABRA6 Q16445 3/20 0.64
GABRA4 P48169 2/20 0.64
KDM4E B2RXH2 1/20 0.64
GABRP O00591 1/20 0.64
GABRD O14764 1/20 0.64
IKBKB O14920 1/20 0.64
AURKA O14965 1/20 0.64
ALDH1A1 P00352 1/20 0.64
PIM1 P11309 1/20 0.64
TOP1 P11387 1/20 0.64
IDO1 P14902 1/20 0.64
HPGD P15428 1/20 0.64
GABRB1 P18505 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29386403 0.82 CDK4 (0.57) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL149685 0.82 CDK4 (0.57) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL12001022 0.82 CDK4 (0.57) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL17154708 0.82 CDK4 (0.57) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL19041639 0.82 CDK4 (0.57) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL30300831 0.82 CDK4 (0.57) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL3365890 0.82 CDK4 (0.57) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL28009141 0.82 CHUK (0.57) CHUKGABRA1GABRG2GABRB3GABRA5
SCHEMBL31174326 0.81 MKNK1 (0.57) CHUKGABRA1GABRG2GABRB3GABRA5
SCHEMBL7647500 0.81 AHR (0.61) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115304597-A Beta-carboline compounds and application thereof in preparing medicines for treating or preventing tumor diseases 中国科学院深圳先进技术研究院 2022-11-08 CN disclosed
EP-3069392-B1 COMPOUND WITH NOVEL SIX-MEMBERED RING STRUCTURE FOR USE IN ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-08-07 EP disclosed
US-10374167-B2 Compound with novel six-membered ring structure for use in organic electronic devices MERCK PATENT GMBH (DE) 2019-08-06 US disclosed
US-20160301016-A1 COMPOUND WITH NOVEL SIX-MEMBERED RING STRUCTURE FOR USE IN ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2016-10-13 US disclosed
US-20160301016-A1 COMPOUND WITH NOVEL SIX-MEMBERED RING STRUCTURE FOR USE IN ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2016-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10374167-B2 Compound with novel six-membered ring structure for use in organic electronic devices OCIAD2, OCIAD1, NR1D2 CHUK 3533/4885GABRA1 3476/4885GABRG2 4126/4885
US-20160301016-A1 COMPOUND WITH NOVEL SIX-MEMBERED RING STRUCTURE FOR USE IN ORGANIC ELECTRONIC DEVICES OCIAD2, OCIAD1, NR1D2 CHUK 3533/4885GABRA1 3476/4885GABRG2 4126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.